Cargando…
多色标记免疫组织化学染色和免疫荧光染色在肺癌免疫治疗中的研究进展
Lung cancer is the most common malignancy and is a major public health problem worldwide. Programmed cell death receptor 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors provide a new treatment strategy for non-small cell lung cancer (NSCLC). The existing biomarkers all have advantages and...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849039/ https://www.ncbi.nlm.nih.gov/pubmed/33478189 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.47 |